WHO ICTRP trial
Effect of medroxyprogesterone versus placebo after hysteroscopic polypectomy on…
IRCT20120215009014N543 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20120215009014N543 |
|---|---|
| Public title | Effect of medroxyprogesterone versus placebo after hysteroscopic polypectomy on the clinical response and recurrence of endometrial polyp |
| Scientific title | Effect of medroxyprogesterone versus placebo after hysteroscopic polypectomy on the clinical response and recurrence of endometrial polyp: a single-blind randomized clinical trial |
| Primary sponsor | Hamedan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Endometrial polyp. Endometrial hyperplasia;N85.0 |
| Interventions | Intervention 1: Intervention group: Routine treatment plus medroxyprogesterone tablets 10 mg twice daily after surgery for 10 days and then 10 mg daily in the luteal phase of subsequent cycles for ten days and for 4 cycles. Intervention 2… |
| Registration date | Nov 30, 2024 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: